|
|
||||||||
Ann Thorac Surg 1996;61:1039-1040
© 1996 The Society of Thoracic Surgeons
Section of Cardiovascular Surgery, Mayo Clinic, 200 First St, Sw, Rochester, Mn 55905
To the Editor:
Topical use of aprotinin has recently been shown to reduce postoperative blood loss in patients undergoing cardiac operations [1, 2]. It has been suggested that a local fibrinolytic state persists after closure of the thoracic cavity and contributes to the postoperative blood loss [3]. Topical aprotinin seems to exert an antifibrinolytic action and potentially stabilizes fibrin sealing of the surgical wound [4].
The number of reoperations has been steadily increasing with the expanding volume of cardiac surgery. Reoperations carry higher morbidity and mortality. The reported incidence of severe hemorrhage during sternal reentry is 2% to 6% [5]. The presence of dense mediastinal adhesions at reoperation obscures the cardiac anatomy and complicates the dissection, increasing the risk of injury to coronary bypass grafts, extracardiac conduits, great vessels, or even the heart itself. Furthermore, adhesions may have a deleterious effect on cardiac function and lead to decreased graft patency [6, 7].
Mesothelial cells are known to secrete physiologically abundant tissue-type plasminogen activator (t-PA) and therefore have an actual or potential role in preventing formation of the adhesions between organs [8, 9]. Porter and associates [10] and Gervin and associates [11] demonstrated the fibrinolytic properties of the mesothelial pericardial tissue. Nkere and colleagues [12, 13] have recently shown significant reductions in pericardial t-PA and plasminogen activating activity during cardiopulmonary bypass. They also suggested that reduction of local fibrinolytic activity associated with pericardial damage may contribute to development of fibrous pericardial adhesions.
Several methods have been tried to reduce postoperative pericardial adhesion formation. Fibrinolytic drugs have been widely investigated for the reduction of adhesions, especially in the abdominal cavity. Dorr and associates [14] demonstrated that enhancing fibrinolytic activity with topical t-PA after mesothelial injury may prevent adhesion formation in the peritoneum. Cross and colleagues [15] reported the successful use of intrapericardial streptokinase to aid in drainage of postoperative loculated pericardial effusion. More recently, Wiseman and co-workers [16] have used fibrinolytic agents t-PA, a t-PA analogue (Fb-Fb-CF), and streptokinase in a rabbit pericardial adhesion model. Adhesions of the anterior cardiac surface were reduced in area from 89% in controls to 28% by treatment with t-PA analogue and 49% by treatment with streptokinase. The results of these studies support the view that there at least is a component of impaired or reduced fibrinolytic activity in adhesion formation.
In their recent study published in The Annals, O'Regan and associates [2] hypothesized that postoperative pericardial adhesion formation may be inhibited by topical aprotinin therapy. However, aprotinin is shown to inhibit plasmin and kallikrein and to inactivate anticoagulant factor protein C, and thus functions as an antifibrinolytic agent. Current data suggest that pericardial adhesion formation is highly dependent on fibrin deposition or impairment of mesothelial fibrinolytic activity. We therefore propose that although topical aprotinin has clearly been beneficial in reducing postoperative mediastinal bleeding in cardiopulmonary bypass cases, its use in the pericardial cavity may enhance postoperative mediastinal adhesion formation through its antifibrinolytic effects.
References
This article has been cited by other articles:
![]() |
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom Transfusion Therapy and Blood Conservation Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430. [Full Text] |
||||
![]() |
D. Baric, B. Biocina, D. Unic, Z. Sutlic, I. Rudez, V. B. Vrca, K. Brkic, and M. Ivkovic Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom Transfusion Therapy and Blood Conservation Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |